Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders. (2018)
Attributed to:
Biological mechanisms underlying the onset and outcome of cannabis-associated psychosis.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.schres.2018.02.050
PubMed Identifier: 29519756
Publication URI: http://europepmc.org/abstract/MED/29519756
Type: Journal Article/Review
Volume: 199
Parent Publication: Schizophrenia research
ISSN: 0920-9964